occasionally hyporeflexia 5 . Serum magnesium level is tightly regulated in a narrow range of approximately 0.7 to 1.0 m mol / L because only 1% of the total body content of magnesium is extracelluler. Magnesium deficiency is identified when serum ionized magnesium level falls below 0.7 m mol / L although patients remain asymptomatic. Symptoms appear when level falls below 0.5 m mol/ L 2 .
Serum magnesium progressively declined during pregnancy reaching a nadir at 34 weeks and then rises up to term 6 . Statistically significant fall in serum magnesium has been observed in pre-eclampsia & eclampsia. In eclampsia serum magnesium was markedly reduced than in pre-eclampsia. Administration of magnesium sulfate to these patients were beneficial in relieving severity of the disease 7 . One study showed that abnormally low concentration of ionized magnesium in the serum is responsible for eclamptic convulsion 2 .
Bangladesh J Obstet Gynaecol, 2010; Vol. 25(1) : [15] [16] [17] [18] [19] . Magnesium has been established as an essential element for fetal well-being. Its deficiency during pregnancy has been reported to be associated with eclampsia, pre-eclampsia, preterm birth, increased maternal hospitalization, incidence of low birth weight & small for gestational age infants. 8 So there is a relation between the low level of serum magnesium of pregnant women & the development of pre-eclampsia & eclampsia. Supplementation of these elements to diet may be of value to prevent preeclampsia & eclampsia. Oral magnesium supplementation during pregnancy improves the maternal morbidity & mortality & also improves the fetal outcome 8 .
Materials and Methods:
This descriptive cross sectional study was carried out from July 2009 to June 2010 in the Department of Obstetrics & Gynaecology, Mymensingh Medical college Hospital & Prof. Muhammed Hussain Central Laboratory", BAU. Among the admitted patient total 120 was taken with proper selection criteria. Of which 60 were the study subjects (pregnant women with pre-eclampsia & eclampsia) and 60 were control subjects (the normotensive pregnant women).
Assessment of serum magnesium is done in this study by photometric test using xylidyl blue. Patients were diagnosed as case and control by history, appropriate clinical examination and urine albumin test by heat coagulation test.
In each case, information about the patients were recorded in structured questionnaire after obtaining written consent of the patients/guardians in the consent form. 5 ml of venous blood was collected from each subject (both study and control group) with all aseptic precautions using sterile disposable plastic syringe by anticubital venipuncture and poured into a clean glass test tube. The collected blood was allowed to clot at room temperature. Fluid was separated by centrifugation for 10 minutes. The sera obtained by centrifuging were kept in eppendrofs tube after proper labeling. Maternal serum magnesium level was categorized into three groups-one group having serum magnesium level of < 1.8 mg/dl. Next group having serum magnesium level of 1.8 mg/dl & another group having serum magnesium level of > 1.8 mg/dl. Calculated data were arranged in systemic manner, presented in various tables and figures. Statistical analysis was made to evaluate the objectives of this study with the help of Statistical Package for Social Science (SPSS, Version 11.5). Level of significance was expressed as P value. P value <0.05 was considered as significant.
Results
The patient characteristics as mean maternal age, parity, mean gestational age and mean economic status are shown in table I. The result showed that statistically very significant (P<0.01) difference in case of antenatal care status between the two groups in table II. The highest (82%) of study group have no antenatal care. Only 67% of control group have regular antenatal care. Highest number of patient was observed having systolic BP (140-160 mm of Hg) and diastolic BP (90-100 mm of Hg). Second highest number 23% having systolic BP (161-200mm of Hg) and about 17% having diastolic BP above 110 mm of Hg (figure I). 
Discussion
Pre-eclampsia/eclampsia is the most common serious medical disorder of human pregnancy, which complicates approximately 5-7% of pregnancy. 9 Magnesium sulphate halves the risk of eclampsia and reduces the risk of maternal death. 10 In our study the result shows statistically highly significant difference (P<0.001) of serum magnesium between study and control group. Serum magnesium of eclamptic patient was significantly lower than that of pre-eclamptic patient (p=<0.05).It supported the results of previous studies. Patil and Choudhari showed that statistically significant fall (p=<0.05) in serum magnesium has been observed in preeclampsia and eclampsia. The difference between serum magnesium level of pre-eclampsia and eclampsia is statistically significant (P=<0.05) 7 . Sukonpan and Pfupong found that serum magnesium concentration in pre-eclamptic women was significantly lower than that in normal pregnant women (p=0.001). 11 Jain et al. showed that the reduction in serum levels of calcium, magnesium, and zinc during pregnancy might be possible contributors in etiology of pre-eclampsia and supplementation of these elements to diet may be of value to prevent preeclampsia 12 . Idogum, Imarengiaye and Momob observed that there was extracellular calcium and magnesium reduction in patients with pre-eclampsia and eclampsia and reduction may have a cause and effect relationship with these disorders. 13 The Akther and Rashid reported that abnormally low concentration of ionized magnesium in the serum is responsible for eclamptic convulsion . 2 Anwary showed in her study which was conducted in BSMMU, the pretreatment magnesium level of eclamptic patient was significantly lower than the control. 14 In another study conducted by Vahidrodsari et all. in 2008, the result support the hypothesis on the role of magnesium deficiency in pre-eclampsia pathophysiology and suggest the usefulness of its assessment in the early diagnosis of the disorder. 15 In Bangladesh the reduction of maternal mortality from eclampsia from 16% (in 1997) to 8.6% (1998-2000) occurred due to changing protocol from diazepam to magnesium sulphate for control of convulsion. 16 This study showed a statistically significant difference between case and control group regarding antenatal care (ANC) status in which 82% of the study group had no ANC. This result is consistent with one previous study conducted by Akther 72% of the study group had no ANC. 2 The finding of another study was that only 2.3% women end their pregnancy under medical supervision (whether it be abortion or delivery); the rest have no access to obstetric care. Most of the eclamptic patients are born in rural areas and belong to a lower social class. As a result most have never received antenatal care. 16 Maternal serum magnesium level tends to decrease gradually when the number of para increases in control group. This findings is very much consistent with the result of a community based cross-sectional study that was conducted in a rural community of Hariana State, India. The finding was that there was a significant decrease (P=0.01) in serum magnesium levels with the increase in parity. 8 In our study all the eclamptic and severe pre-eclamptic mothers received magnesium sulfate as therapeutic and prophylactic purpose respectively and the outcome was excellent. This result indicate that there was hypomagnesaemic condition developed in these study group which was also observed by the estimation of serum magnesium of the study and control group. So estimation of serum magnesium of pregnant women during antenatal period should be done to detect pre-eclampsia in high risk group and thereby to prevent eclampsia. Oral magnesium preparations should be supplemented during prepregnancy or early pregnancy for prevention of preeclampsia and eclampsia. Routine use of magnesium preparations during antenatal period may improve the neonatal outcome also.
